| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 04/07/2005 | WO2005030166A1 Oros push-stick for controlled delivery of active agents |
| 04/07/2005 | WO2005030165A1 Dosage form for controlled release of an active agent formulation |
| 04/07/2005 | WO2005030164A2 Improved controlled release dosage form including a banded engine |
| 04/07/2005 | WO2005030142A2 Rifalazil formulations |
| 04/07/2005 | WO2005030132A2 Therapeutic regimens for administering drug combinations |
| 04/07/2005 | WO2005030126A2 Adhesin-specific nanoparticles and process for using same |
| 04/07/2005 | WO2005009472A3 Dispersible pharmaceutical composition for treatment of mastitis and otic disorders |
| 04/07/2005 | WO2005009428A3 Orodispersible pharmaceutical composition of an antithrombotic compound |
| 04/07/2005 | WO2005009415A3 Novel method for microparticles production |
| 04/07/2005 | WO2005009395A3 Cellulosic fiber containing composition |
| 04/07/2005 | WO2004113286A3 Mucin synthesis inhibitors |
| 04/07/2005 | WO2004112756A8 Proton pump-inhibitor-containing capsules which comprise subunits differently structured for a delayed release of the active ingredient |
| 04/07/2005 | WO2004112695A3 Methods and compositions for delivery of catecholic butanes for treatment of obesity |
| 04/07/2005 | WO2004108760A3 Improved secretion of neublastin |
| 04/07/2005 | WO2004096155A3 Tablets and methods for modified release of hydrophilic and other active agents |
| 04/07/2005 | WO2004093795A3 Compositions for delivery of drug combinations |
| 04/07/2005 | WO2004091538A3 Homogeneous, thermoreversible alginate films and soft capsules made therefrom |
| 04/07/2005 | WO2004091498A3 Alcohol-free transdermal insulin composition and processes for manufacture and use thereof |
| 04/07/2005 | WO2004070009A3 Targeted multivalent macromolecules |
| 04/07/2005 | WO2004030651A3 Method, compounds and preparations for the identification of sentinel lymph nodes |
| 04/07/2005 | WO2004020189A8 Embossable and writable multilaminate backing construction |
| 04/07/2005 | WO2004002422A3 2’-c-methyl-3’-o-l-valine ester ribofuranosyl cytidine for treatment of flaviviridae infections |
| 04/07/2005 | WO2003083443A3 Lipid mediated screening of drug candidates for identification of active compounds |
| 04/07/2005 | WO2003015783A8 Method of treating alcoholism or alcohol abuse |
| 04/07/2005 | US20050075627 Antibiotic drug delivery system |
| 04/07/2005 | US20050075619 Container for linezolid intravenous solution |
| 04/07/2005 | US20050075559 Ingestible device |
| 04/07/2005 | US20050075407 Foam incorporating eutetic mixture |
| 04/07/2005 | US20050075391 Nitric oxide donor composition and method for treatment of anal disorders |
| 04/07/2005 | US20050075350 Adding a pyridonecarboxylic acid comprising lomefloxacin, norfloxacin, ofloxacin, enoxacin, ciprofloxacin, tosufloxacin, fleroxacin and/or levofloxacin; cinoxacin, sparfloxacin or salt; low temperature; antiinflammatory agents |
| 04/07/2005 | US20050075335 Pharmaceutical composition comprising n((1-n-butyl-4-piperidinyl)methyl)-3,4-dihydro-2h-(1,3)oxazino(3,2-a)indole-10-carboxamide or salt and process therefor comprising dry granulation |
| 04/07/2005 | US20050075330 Dipeptidyl peptidase inhibitors |
| 04/07/2005 | US20050075329 S-tofisopam, a prodrug or a salt thereof, free of its R enantiomer, and a carrier; may also contain one or more other anticonvulsants |
| 04/07/2005 | US20050075319 Method of treatment using bisphosphonic acid |
| 04/07/2005 | US20050075313 Ophthalmic compositions containing galactomannan polymers and borate |
| 04/07/2005 | US20050075297 Adding water (15-79%) to a mixture of ribavirin and three excipients (binder, filler and disintegrant); drying the granulated particles and shaping; encapsulation; dustless; uniformity; greater control of dissolution rates; better flow characteristics; faster encapsulation and lower weight variations |
| 04/07/2005 | US20050075296 for extending the release times and decreasing the toxicity, by using a di-lauric acid salt of tilmicosin in an acceptable solvent, which forms a precipitate when injected into water; treating infections in dogs and cats where tilmicosin was previously too toxic |
| 04/07/2005 | US20050075288 Pharmaceutical and cosmetic compositions comprising plgf-1 |
| 04/07/2005 | US20050075284 peptide analogues or conjugates of vasoactive intestinal peptide(VIP), used for vaginal relaxation and/or for modulation of sperm motility |
| 04/07/2005 | US20050075273 condensation aerosols; for treatment of pain or alcohol abuse; kits |
| 04/07/2005 | US20050075271 Crystalline beta2 adrenergic receptor agonist |
| 04/07/2005 | US20050074866 Mixture comprising antihemophilic and/or von willebrand factors, antithrombin and sodium heparin for use as tool in treatment of blood disorders |
| 04/07/2005 | US20050074813 Model for testing immunogenicity of peptides |
| 04/07/2005 | US20050074551 Ethylene glycol monolayer protected nanoparticles |
| 04/07/2005 | US20050074526 Method for a consumer to individually flavor his own dairy dessert |
| 04/07/2005 | US20050074525 Method for a consumer to flavor breakfast breads in his own home or in a restaurant |
| 04/07/2005 | US20050074518 Chewing gum-containing tablet |
| 04/07/2005 | US20050074514 Zero cycle molding systems, methods and apparatuses for manufacturing dosage forms |
| 04/07/2005 | US20050074504 Use of borate-polyol complexes in ophthalmic compositions |
| 04/07/2005 | US20050074498 Perforated microstructure; flowability, dispersibility; stable aerosols; respiratory inhalants |
| 04/07/2005 | US20050074497 Sustained release delivery systems; contact lens shape; includes vision correction; lower dosage antiangiogenesis therapeutics; reduced local inflammation and/or adverse systemic reactions; macular degeneration; retinopathies |
| 04/07/2005 | US20050074496 Utilizing such as fucoidan to treat surgical adhesions, arthritis, psoriasis; nontoxic, reduced side effects |
| 04/07/2005 | US20050074495 Compositions of polyacids and methods for their use in reducing adhesions |
| 04/07/2005 | US20050074494 Itraconazole immediate release formulation |
| 04/07/2005 | US20050074493 Once daily pain relief formulations; consistent plasma concentration; customizable profiles |
| 04/07/2005 | US20050074492 Sustained release ionic conjugate |
| 04/07/2005 | US20050074491 Universal controlled-release composition |
| 04/07/2005 | US20050074490 Controlled release composition |
| 04/07/2005 | US20050074489 Convenient, effective delivery; easy to swallow; low cost |
| 04/07/2005 | US20050074488 Use of vitamin Ds to down regulate the renin-angiotensin-aldosterone system |
| 04/07/2005 | US20050074487 Transdermal and topical administration of drugs using basic permeation enhancers |
| 04/07/2005 | US20050074484 Facial mask; addresses needs of individual regions |
| 04/07/2005 | US20050074482 Skin-compatible hydrogel adhesives and personal care products containing them |
| 04/07/2005 | US20050074470 Compounds, methods and pharmaceutical compositions for treating cellular damage, such as neural or cardiovascular tissue damage |
| 04/07/2005 | US20050074469 Storable and shippable concentrates; mixable with polymer formulations without heating, homogenizing or cooling |
| 04/07/2005 | US20050074468 Topical compositions containing nonimmunosuppressive cyclosporin derivatives for treating hair loss |
| 04/07/2005 | US20050074461 Transdermal botulinum toxin compositions |
| 04/07/2005 | US20050074449 Microparticle formulations; controlling immune response; including surfactants, excipients and antigens |
| 04/07/2005 | US20050074441 probiotics having immunomodulatory activity, used for prophylaxis gastrointestinal disorders such as inflammatory bowel disease or irritable bowel syndrome |
| 04/07/2005 | US20050074414 Penetrating pharmaceutical foam |
| 04/07/2005 | US20050074413 Good cosmetic and styling properties without making the hair sticky |
| 04/07/2005 | US20050074407 polyvinylpyrrolidone and polyvinyl alcohol water based gel; alkylene glycols, polyalkylene glycols added to adjust texture and drying characteristics |
| 04/07/2005 | US20050072430 Nasal devices |
| 04/07/2005 | DE10392512T5 Implantierbares druckbetätigtes Mikroventil Implantable pressure actuated microvalve |
| 04/07/2005 | CA2581996A1 Buccal, polar and non-polar spray containing alprazolam |
| 04/07/2005 | CA2580733A1 (-)-hydroxycitric acid for delaying gastric emptying |
| 04/07/2005 | CA2540488A1 Pharmaceutical formulation with improved stability |
| 04/07/2005 | CA2540101A1 Improvements in powder compaction and enrobing |
| 04/07/2005 | CA2540059A1 Controlled release formulations exhibiting an ascending rate of release |
| 04/07/2005 | CA2540056A1 Controlled release formulations of opioid and nonopioid analgesics |
| 04/07/2005 | CA2540050A1 Osmotic dosage forms for controlled delivery of alprazolam |
| 04/07/2005 | CA2540045A1 Dosage form for controlled release of an active agent formulation |
| 04/07/2005 | CA2540044A1 Improved controlled release dosage form including a banded engine |
| 04/07/2005 | CA2540005A1 Pulmonary disease treatment |
| 04/07/2005 | CA2539694A1 Clostridium botulinum c3 exotransferase compositions and methods for treating tumour spreading |
| 04/07/2005 | CA2539542A1 Delivery of therapeutic compounds via microparticles or microbubbles |
| 04/07/2005 | CA2539486A1 Methods for preparing oil bodies comprising active ingredients |
| 04/07/2005 | CA2539472A1 Ocular solutions containing a macrolide antibiotic and/or mycophenolic acid |
| 04/07/2005 | CA2539238A1 Altering animal waste composition |
| 04/07/2005 | CA2538676A1 Probiotic storage and delivery |
| 04/07/2005 | CA2538023A1 Therapeutic regimens for administering drug combinations |
| 04/07/2005 | CA2537874A1 Therapeutic agent for ageing macular degeneration |
| 04/06/2005 | EP1520897A1 Adhesive structures for attachment to skin |
| 04/06/2005 | EP1520799A1 Medicament carrier |
| 04/06/2005 | EP1520581A1 Composition based on a thiazolidinedione and metformin and its use |
| 04/06/2005 | EP1520579A1 Compositions for the treatment and prevention of cancer |
| 04/06/2005 | EP1520578A1 Medicinal suspensions |
| 04/06/2005 | EP1520000A1 Catalyst for conversion processes |
| 04/06/2005 | EP1519979A1 Poly-gamma-glutamate having ultra high molecular weight and method for using the same |
| 04/06/2005 | EP1519962A1 Ester derivatives of hyaluronic acid for the preparation of hydrogel materials by photocuring |